Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katarzyna Haynesworth
Observed names:
Haynesworth, Katarzyna,
K. Haynesworth
Institution:
Frederick National Laboratory for Cancer Research
Observed institutions:
Frederick National Laboratory for Cancer Research,
Meso Scale Discovery (United States),
Leidos Biomedical Research Inc. (United States)
ORCID:
0009-0009-4573-3607
Observed ORCID:
0009-0009-4573-3607
OpenAlex ID:
A5067259986
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
2017
·
G.B. Sigal
, M.R. Segal
, et al.
·
EBioMedicine
·
135
PDF
Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination
2024
·
Jimmie L. Bullock
, Thomas E. Hickey
, et al.
·
Vaccines
·
17
Development, Validation, and Utilization of a Luminex-Based SARS-CoV-2 Multiplex Serology Assay
2023
·
Daisy R. Roy
, Troy J. Kemp
, et al.
·
Microbiology Spectrum
·
11
Analytical measuring interval, linearity, and precision of serology assays for detection of SARS-CoV-2 antibodies according to CLSI guidelines
2024
·
Katarzyna Haynesworth
, Troy J. Kemp
, et al.
·
mSphere
·
10
Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatment
2025
·
Christine M. Dang
, Troy J. Kemp
, et al.
·
Human Vaccines & Immunotherapeutics
·
2
PDF
Blood collection tube and anticoagulant influence on SARS-CoV-2 antibody and avidity levels
2024
·
Nicholas C. Castro
, Jimmie Bullock
, et al.
·
Heliyon
·
2
Measuring Humoral Immune Responses to SARS-CoV-2: A Comprehensive Review of Serological Assays
2026
·
Huijing Xue
, Katarzyna Haynesworth
, et al.
·
Vaccines
·
1
PDF
Show more works
View as search
Works count:
9
Citation count:
178
H-index:
4
I10-index:
4
Year
Topic
Type